Clozapine

氯氮平

Report date: 2023/02/09 20:00:50
NME

Base Information

Drug NameClozapine
Drug Alias Name氯扎平clozapinumclozapinaFazacloLeponex +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine receptors antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine receptors
Therapy Area/IndicationsSchizophreniaBipolar Disorder
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryUnited StatesSouth KoreaEU +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHls Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesWhanin Pharmaceutical CompanyHeritage LifeNovartis Pharmaceuticals Corp +[5] 
Inactive CompaniesDong Wha Pharm Co LtdNovartis Pharma AgNorthwell Health, Inc +[4] 
Active IndicationsSchizophrenia
Inactive IndicationsBipolar Disorder

Other Information

ATC CodeN05AH02
Related LinksWikipediaDrugBankKEGG